Idenix Pharmaceuticals, Inc., (Nasdaq: IDIX) said it met with the FDA on November 30 to discuss the clinical development program ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE